Abstract 4367: ERAS-4001 is a pan-KRAS inhibitor with robust anti-tumor activity in KRAS altered solid tumors
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Jae Hyun Bae, Bingzhen Lin, Erin D. Lew, Alexei Brooun, Joanne Oh, Taylor Sullivan, Corine Holub, Alex Stromitis, Brian Qua, Robert F. Shoemaker
Institution: Erasca (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409625600